Specificity of nerve growth factor signaling: differential patterns of early tyrosine phosphorylation events induced by NGF, EGF, and bFGF.
The specificity of nerve growth factor (NGF) action was examined by comparing early tyrosine phosphorylation events induced by NGF, epidermal growth factor (EGF), and basic fibroblast growth factor (bFGF). In PC12 cells, administration of either the differentiation factor NGF or the mitogenic factor EGF led to tyrosine phosphorylation of multiple polypeptides in the 100-110 kDa size range associated with PI-3 kinase. However, NGF induced a more prolonged phosphorylation, relative to a transient EGF effect. In contrast, the differentiation factor bFGF failed to induce measurable tyrosine phosphorylation of PI-3 kinase-associated proteins. Similarly, NGF but not bFGF induced marked tyrosine phosphorylation of PLC gamma, another early signaling molecule, suggesting that multiple pathways exist for promoting differentiation, and/or that these signaling molecules are not essential for differentiation. TrkA signaling was also compared between PC12 cells and NIH-3T3 cells heterologously expressing trkA, where receptor activation promotes mitogenesis. In this comparison, significant differences were observed in the tyrosine phosphorylation pattern of PI-3 kinase-associated polypeptides, suggesting the existence of cell type-specific molecular interactions influencing trkA signaling. Mechanistically, NGF stimulation of PC12 cells resulted in a weak or possibly indirect association between trkA and PI-3 kinase. Furthermore, NGF did not appear to activate or substantially alter the overall level of PI-3 kinase activity, raising the possibility that ligand-induced phosphorylation may serve instead to relocalize constitutively active PI-3 kinase molecules within the cell. Taken together, data presented suggest that the temporal pattern of induced phosphorylation, the nature of induced associations with other phosphoproteins, and cell type-specific components may all contribute to the generation of NGF signaling specificity.
Blumberg
D
D
Neuroscience Research Institute, University of California, Santa Barbara 93106, USA.
Radeke
M J
MJ
Feinstein
S C
SC
D016475:3T3 Cells; D000818:Animals; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D007527:Isoenzymes / Q000378:metabolism; D051379:Mice; D009414:Nerve Growth Factors / Q000494:pharmacology* / Q000502:physiology*; D016716:PC12 Cells; D019869:Phosphatidylinositol 3-Kinases; D051966:Phospholipase C gamma; D010766:Phosphorylation / Q000187:drug effects; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000378:metabolism; D051381:Rats; D020917:Receptor, trkA / Q000502:physiology; D015398:Signal Transduction; D010738:Type C Phospholipases / Q000378:metabolism; D014443:Tyrosine / Q000378:metabolism*
D007527:Isoenzymes; D009414:Nerve Growth Factors; D016222:Fibroblast Growth Factor 2; D014443:Tyrosine; D004815:Epidermal Growth Factor; D019869:Phosphatidylinositol 3-Kinases; D017853:Phosphotransferases (Alcohol Group Acceptor); D020917:Receptor, trkA; D010738:Type C Phospholipases; D051966:Phospholipase C gamma